Stereotaxis
St Louis
About Stereotaxis
Stereotaxis focuses on the development of robotic cardiology instrument navigation systems designed to enhance the treatment of arrhythmias and coronary disease, as well as information management solutions for the interventional lab. With over 100 patents for use in a hospital's interventional surgical suite, Stereotaxis helps physicians around the world provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced collaboration of life-saving information. Stereotaxis' core technologies are the Niobe® ES Remote Magnetic Navigation system, the Odyssey™ portfolio of lab optimization, networking and patient information management systems and the Vdrive™ Robotic Mechanical Navigation system and consumables.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $166.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Aug 2025)
- Ticker: otcqx:STXS
- Website: stereotaxis.com
- Phone: (314) 678-6300
Industries & Categories
Biotechnology, Health Care, Medical Device, Navigation
Social Profiles
Canonical: https://fsome.com/organization/stereotaxis-53163 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.